日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LRRC15-CAR T Cells for the Treatment of Osteosarcoma.

LRRC15-CAR T 细胞用于治疗骨肉瘤。

O'Reilly Carla, Tuladhar Shraddha, Nguyen Phuong, Sheppard Heather, Koo Selene C, Chockley Peter, Houke Haley, Santiago Teresa, Tian Liqing, Jeschke Julie, Beckett Alex N, Chabot Ashley, Yustein Jason, Krenciute Giedre, Talbot Lindsay J, Gottschalk Stephen, DeRenzo Christopher

Targeting Regnase-1 unleashes CAR T cell antitumor activity for osteosarcoma and creates a proinflammatory tumor microenvironment

靶向Regnase-1可释放CAR T细胞对骨肉瘤的抗肿瘤活性,并创造促炎性肿瘤微环境。

Adeshakin, Adeleye O; Shi, Hao; Perry, S Scott; Sheppard, Heather; Nguyen, Phuong; Sun, Xiang; Zhou, Peipei; Métais, Jean-Yves; Cunningham, Trevor; Anil, K C; Tian, Liqing; Peche, Vivek; Prater, Mollie S; Langfitt, Deanna M; Pruett-Miller, Shondra M; Yustein, Jason T; Krenciute, Giedre; DeRenzo, Christopher; Chi, Hongbo; Gottschalk, Stephen

Pulmonary thrombectomy and extracorporeal membrane oxygenation: a case study

肺血栓切除术和体外膜肺氧合:病例研究

DeRenzo, Mariah

Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy

克隆造血的表观遗传调控因子在免疫治疗过程中控制 CD8 T 细胞干性

Kang, Tae Gun; Lan, Xin; Mi, Tian; Chen, Hongfeng; Alli, Shanta; Lim, Song-Eun; Bhatara, Sheetal; Vasandan, Anoop Babu; Ward, Grace; Bentivegna, Sofia; Jang, Josh; Spatz, Marianne L; Han, Jin-Hwan; Schlotmann, Balthasar Clemens; Jespersen, Jakob Schmidt; Derenzo, Christopher; Vogel, Peter; Yu, Jiyang; Baylin, Stephen; Jones, Peter; O'Connell, Casey; Grønbæk, Kirsten; Youngblood, Ben; Zebley, Caitlin C

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

晚期肉瘤淋巴细胞清除后自体 HER2 特异性 CAR-T 细胞治疗:一项 1 期临床试验

Meenakshi Hegde, Shoba Navai, Christopher DeRenzo, Sujith K Joseph, Khaled Sanber, Mengfen Wu, Ahmed Z Gad, Katherine A Janeway, Matthew Campbell, Dolores Mullikin, Zeid Nawas, Catherine Robertson, Pretty R Mathew, Huimin Zhang, Birju Mehta, Raksha R Bhat, Angela Major, Ankita Shree, Claudia Gerken,

DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma

DNAJB1-PRKACA融合新抗原可诱导罕见的内源性T细胞反应,从而增强纤维板层癌的细胞疗法疗效。

Allison M Kirk ,Jeremy Chase Crawford ,Ching-Heng Chou ,Cliff Guy ,Kirti Pandey ,Tanya Kozlik ,Ravi K Shah ,Shanzou Chung ,Phuong Nguyen ,Xiaoyu Zhang ,Jin Wang ,Matthew Bell ,Robert C Mettelman ,E Kaitlynn Allen ,Mikhail V Pogorelyy ,Hyunjin Kim ,Anastasia A Minervina ,Walid Awad ,Resha Bajracharya ,Toni White ,Donald Long Jr ,Brittney Gordon ,Michelle Morrison ,Evan S Glazer ,Andrew J Murphy ,Yixing Jiang ,Elizabeth A Fitzpatrick ,Mark Yarchoan ,Praveen Sethupathy ,Nathan P Croft ,Anthony W Purcell ,Sara M Federico ,Elizabeth Stewart ,Stephen Gottschalk ,Anthony E Zamora ,Christopher DeRenzo ,Scott E Strome ,Paul G Thomas

A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCα activation

FDA 批准的增强 CAR-T 细胞功能的药物的高内涵筛选:当归醇-3-酸酯通过激活 PKCα 上调靶细胞表面的 B7-H3,从而提高 B7-H3-CAR-T 细胞活性

Ha Won Lee, Carla O'Reilly, Alex N Beckett, Duane G Currier, Taosheng Chen, Christopher DeRenzo

Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models

将B7-H3.CAR T细胞重定向至骨肉瘤中表达的趋化因子可增强其在临床前模型中的归巢能力和抗肿瘤活性。

Lindsay J Talbot ,Ashley Chabot ,Aaron B Ross ,Alexandra Beckett ,Phuong Nguyen ,Andrew Fleming ,Peter J Chockley ,Heather Shepphard ,Jian Wang ,Stephen Gottschalk ,Christopher DeRenzo

CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives

CAR-T细胞靶向B7-H3治疗儿童实体瘤:现状与展望

Epperly, Rebecca; Gottschalk, Stephen; DeRenzo, Christopher

CD47 expression is critical for CAR T-cell survival in vivo

CD47表达对于CAR T细胞在体内的存活至关重要。

Beckett, Alex N; Chockley, Peter; Pruett-Miller, Shondra M; Nguyen, Phuong; Vogel, Peter; Sheppard, Heather; Krenciute, Giedre; Gottschalk, Stephen; DeRenzo, Christopher